Angina Pectoris

Angina Pectoris is a clinical syndrome characterized by substernal chest discomfort or pain, typically described as pressure, heaviness, tightness, or squeezing. It is caused by myocardial ischemia, a temporary imbalance between the heart's oxygen supply and demand. Most commonly, angina is a symptom of underlying coronary artery disease (CAD) resulting from atherosclerosis, but it can also be due to coronary artery spasm or microvascular dysfunction. Angina is usually provoked by physical exertion, emotional stress, or cold weather and is relieved by rest or nitroglycerin.

The primary cause of angina pectoris is atherosclerosis of the coronary arteries, leading to significant narrowing (stenosis) and reduced blood flow to the myocardium. Other etiologies include coronary artery spasm (Prinzmetal's angina), coronary microvascular dysfunction, severe aortic stenosis or regurgitation, hypertrophic cardiomyopathy, and severe anemia, all of which can lead to a supply-demand mismatch of myocardial oxygen.

Angina arises from myocardial ischemia, meaning the heart muscle is not receiving sufficient oxygen. In CAD, atherosclerotic plaques narrow the coronary arteries, impairing blood flow. During periods of increased myocardial oxygen demand (e.g., exercise, stress, cold exposure), the narrowed arteries cannot adequately increase blood supply, leading to ischemia. This oxygen deficit forces myocardial cells to shift to anaerobic metabolism, producing lactic acid and other metabolites. These substances irritate cardiac nerve endings, triggering the characteristic anginal pain.

Angina pectoris is a common manifestation of coronary artery disease. Its prevalence increases with age, affecting approximately 7% of individuals aged 45-64 years and 12-14% of those aged 65-84 years in developed countries. Men typically experience angina at an earlier age, but after menopause, the incidence in women approaches that of men. Globally, the burden of angina is substantial, reflecting the high prevalence of CAD.

• Hypertension (High Blood Pressure)
• Hyperlipidemia (High Cholesterol)
• Diabetes Mellitus
• Smoking
• Obesity (especially abdominal obesity)
• Physical Inactivity
• Family History of premature CAD (first-degree relative: male <55 years, female <65 years)
• Advanced Age
• Male Gender
• Chronic Kidney Disease
• Stress

A. Early Symptoms

• Subtle chest discomfort or heaviness during strenuous activity.


• Mild fatigue or shortness of breath on exertion. B. Common Symptoms


• Substernal chest pain, pressure, tightness, or squeezing.


• Pain radiating to the left arm, shoulder, jaw, neck, back, or epigastrium.


• Shortness of breath (dyspnea).


• Fatigue.


• Nausea.


• Diaphoresis (sweating).


• Indigestion or heartburn-like sensation.


• Symptoms typically provoked by exertion, emotional stress, or cold, and relieved by rest or sublingual nitroglycerin within minutes. C. Advanced Symptoms


• Increased frequency, duration, or intensity of anginal episodes.


• Angina occurring with less exertion or at rest (suggests unstable angina).


• Angina that is less responsive to nitroglycerin. D. Emergency Symptoms


• Sudden onset of severe chest pain that is prolonged (>20 minutes) and not relieved by rest or nitroglycerin.


• Chest pain accompanied by severe shortness of breath, dizziness, fainting (syncope), or signs of shock (e.g., cold clammy skin, confusion).


• New-onset or rapidly worsening angina (unstable angina, a medical emergency).

During an anginal episode, findings may include tachycardia, hypertension, diaphoresis, or pallor. Auscultation might reveal a transient S4 gallop, or sometimes an S

1. Rarely, a new or worsening systolic murmur of mitral regurgitation may be heard due to ischemic papillary muscle dysfunction. Between episodes, the physical exam is often normal unless there are signs of underlying CAD risk factors (e.g., bruits, xanthomas) or other cardiovascular disease.

A. Clinical Assessment
Detailed history of chest pain characteristics (PQRST - Precipitating/Palliating factors, Quality, Radiation, Severity, Timing), risk factor assessment, and review of systems.
B. Laboratory Testing
Cardiac biomarkers (troponin, CK-MB) if acute coronary syndrome is suspected, lipid panel, fasting glucose/HbA1c, complete blood count, thyroid function tests, renal function tests.
C. Imaging Studies
Chest X-ray, Echocardiography, Cardiac CT Angiography, Cardiac MRI.
D. Functional Tests
Electrocardiogram (ECG) (at rest and during stress), Exercise Stress Test (with ECG, echocardiography, or nuclear imaging), Pharmacological Stress Test (dobutamine stress echo, adenosine/regadenoson nuclear stress test).
E. Biopsy Findings
Not routinely used for the diagnosis of angina pectoris.
F. Genetic Testing
Considered in specific cases of familial hypercholesterolemia or other inherited cardiovascular conditions, but not for typical angina.
G. Differential Diagnosis
Myocardial infarction, pericarditis, esophagitis/GERD, musculoskeletal pain, anxiety/panic attacks, pulmonary embolism, aortic dissection.

Troponin I/T
Type: Blood Test
Purpose: To rule out acute myocardial infarction (MI) or myocardial injury.
Expected Findings: Normal levels in stable angina.
Interpretation: Elevated levels indicate myocardial injury/necrosis, suggesting acute coronary syndrome rather than stable angina. Lipid Panel
Type: Blood Test
Purpose: To assess for dyslipidemia, a major risk factor for atherosclerosis.
Expected Findings: Elevated LDL cholesterol, low HDL cholesterol, elevated triglycerides are common in patients with CAD.
Interpretation: Abnormal lipid profile indicates a significant risk factor for progressive coronary artery disease. Glycated Hemoglobin (HbA1c)
Type: Blood Test
Purpose: To screen for or monitor diabetes mellitus or pre-diabetes.
Expected Findings: Elevated levels (>6.5%) in diagnosed or undiagnosed diabetes.
Interpretation: High HbA1c indicates poor glycemic control, a strong risk factor for CAD and its progression.

Electrocardiogram (ECG)
Purpose: Records the electrical activity of the heart.
Typical Findings: May be normal at rest in stable angina. During ischemia, it can show transient ST segment depression, T-wave inversion, or less commonly, ST elevation (Prinzmetal's angina).
Clinical Importance: Identifies signs of myocardial ischemia, prior infarction, or arrhythmias; crucial for stress testing. Echocardiography
Purpose: Uses sound waves to create images of the heart's structure and function.
Typical Findings: May show regional wall motion abnormalities during ischemia, left ventricular hypertrophy, valvular heart disease, or reduced ejection fraction in advanced CAD.
Clinical Importance: Assesses global and regional myocardial function, identifies structural heart disease, and can be used with stress testing to detect inducible ischemia. Coronary Angiography (Cardiac Catheterization)
Purpose: Direct visualization of the coronary arteries using contrast dye and X-rays.
Typical Findings: Identifies location and severity of coronary artery stenoses or occlusions.
Clinical Importance: Considered the gold standard for diagnosing obstructive CAD, guiding decisions for revascularization procedures (PCI or CABG).

Distinguishing angina from other causes of chest pain is critical. Myocardial infarction presents with similar but often more severe, prolonged pain not relieved by rest or nitroglycerin, and associated with cardiac biomarker elevation. Pericarditis typically causes sharp, pleuritic pain that worsens with lying flat and improves with leaning forward. Gastroesophageal reflux disease (GERD) or esophagitis can mimic angina, but pain is often related to meals and relieved by antacids. Musculoskeletal pain is usually localized, reproducible with palpation or movement. Pulmonary embolism and aortic dissection are life-threatening conditions requiring immediate differentiation, characterized by acute dyspnea, pleuritic pain, or severe tearing pain radiating to the back, respectively.

• Acute Myocardial Infarction (Heart Attack)
• Unstable Angina (worsening pattern of angina, a pre-MI state)
• Heart Failure (due to chronic ischemia or previous MI)
• Cardiac Arrhythmias (irregular heartbeats)
• Sudden Cardiac Death
• Progression of Coronary Artery Disease

A. Lifestyle Modifications

• Smoking cessation


• Adoption of a heart-healthy diet (e.g., Mediterranean diet)


• Regular physical activity (at least 150 minutes of moderate-intensity exercise per week)


• Weight management to achieve a healthy BMI


• Stress reduction techniques B. Preventive Measures


• Strict control of blood pressure (target <130/80 mmHg for most)


• Cholesterol management, often with statins


• Glycemic control for diabetes (HbA1c <7%)


• Aspirin (antiplatelet therapy) for most patients with CAD C. Medical Treatment

• Examples: Sublingual nitroglycerin (acute relief), isosorbide dinitrate/mononitrate (long-term prevention).

• Examples: Metoprolol succinate, carvedilol, atenolol.

• Examples: Amlodipine (dihydropyridine), diltiazem, verapamil (non-dihydropyridines).

• Examples: Aspirin (first-line), clopidogrel (if aspirin intolerant or post-stent).

• Examples: Atorvastatin, rosuvastatin, simvastatin.

• Examples: Ranolazine (adjunctive therapy for chronic stable angina). D. Surgical Treatment


• Coronary Artery Bypass Graft (CABG): Open-heart surgery to graft healthy blood vessels around blocked coronary arteries, restoring blood flow. Indicated for multi-vessel CAD, left main disease, or diffuse disease not amenable to PCI. E. Interventional Procedures


• Percutaneous Coronary Intervention (PCI) / Angioplasty with Stenting: A minimally invasive procedure where a catheter with a balloon is inserted to open a narrowed artery, often followed by placement of a stent to keep it open. F. Rehabilitation


• Cardiac Rehabilitation: Structured, medically supervised programs involving exercise training, education on heart-healthy living, and counseling to reduce risk factors and improve quality of life. G. Emergency Management


• For acute anginal pain: Immediately take sublingual nitroglycerin (up to 3 doses 5 minutes apart). If pain persists or worsens after the first dose, or if it is severe and associated with other emergency symptoms, call emergency services immediately (911). Chewing aspirin is also recommended if MI is suspected.

The prognosis for stable angina pectoris is generally good with effective medical management and diligent risk factor modification. Patients who adhere to treatment regimens and adopt healthy lifestyles can significantly reduce their risk of complications. However, angina remains a marker for underlying CAD, and the long-term prognosis depends on the severity of CAD, left ventricular function, and the presence of comorbidities. Unstable angina, by definition, has a poorer prognosis and carries a higher short-term risk of myocardial infarction and death.

Primary Prevention: Focuses on preventing the development of CAD. This includes maintaining a healthy lifestyle (non-smoking, balanced diet, regular exercise, healthy weight), and controlling risk factors such as hypertension, hyperlipidemia, and diabetes through lifestyle and medication if necessary.
Secondary Prevention: Aims to prevent recurrent anginal episodes and complications in individuals already diagnosed with CAD. This involves adherence to prescribed medications (e.g., statins, antiplatelets, beta-blockers), regular follow-up with healthcare providers, and participation in cardiac rehabilitation programs.

The following homeopathic remedies have been historically indicated for symptoms associated with Angina Pectoris. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

📊 TIMI Risk Score for UA/NSTEMI

Estimates 14-day mortality and ischemic outcomes in patients presenting with unstable angina (UA) or non-ST-elevation myocardial infarction (NSTEMI).